Literature DB >> 26215043

Clinical trials: subgroup analyses in randomized trials--more rigour needed.

Douglas G Altman1.   

Abstract

Mesh：

Year:  2015        PMID： 26215043     DOI： 10.1038/nrclinonc.2015.133

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

Review 2.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review.

Authors:  Xin Sun; Matthias Briel; Jason W Busse; John J You; Elie A Akl; Filip Mejza; Malgorzata M Bala; Dirk Bassler; Dominik Mertz; Natalia Diaz-Granados; Per Olav Vandvik; German Malaga; Sadeesh K Srinathan; Philipp Dahm; Bradley C Johnston; Pablo Alonso-Coello; Basil Hassouneh; Stephen D Walter; Diane Heels-Ansdell; Neera Bhatnagar; Douglas G Altman; Gordon H Guyatt
Journal:  BMJ       Date:  2012-03-15

3.  Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

Authors:  Isabelle Boutron; Susan Dutton; Philippe Ravaud; Douglas G Altman
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

4.  Which of these things is not like the others?

Authors:  Jay S Kaufman; Richard F MacLehose
Journal:  Cancer       Date:  2013-09-10       Impact factor: 6.860

5.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

6.  Statistical problems in the reporting of clinical trials. A survey of three medical journals.

Authors:  S J Pocock; M D Hughes; R J Lee
Journal:  N Engl J Med       Date:  1987-08-13       Impact factor: 91.245

7.  Subgroup Analyses in Reporting of Phase III Clinical Trials in Solid Tumors.

Authors:  Sheng Zhang; Fei Liang; Wenfeng Li; Xichun Hu
Journal:  J Clin Oncol       Date:  2015-04-20       Impact factor: 44.544

8.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

Authors:  S Yusuf; J Wittes; J Probstfield; H A Tyroler
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

Review 9.  Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

Authors:  Kerry Dwan; Douglas G Altman; Mike Clarke; Carrol Gamble; Julian P T Higgins; Jonathan A C Sterne; Paula R Williamson; Jamie J Kirkham
Journal:  PLoS Med       Date:  2014-06-24       Impact factor: 11.069

10.  Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.

Authors:  Benjamin Kasenda; Stefan Schandelmaier; Xin Sun; Erik von Elm; John You; Anette Blümle; Yuki Tomonaga; Ramon Saccilotto; Alain Amstutz; Theresa Bengough; Joerg J Meerpohl; Mihaela Stegert; Kelechi K Olu; Kari A O Tikkinen; Ignacio Neumann; Alonso Carrasco-Labra; Markus Faulhaber; Sohail M Mulla; Dominik Mertz; Elie A Akl; Dirk Bassler; Jason W Busse; Ignacio Ferreira-González; Francois Lamontagne; Alain Nordmann; Viktoria Gloy; Heike Raatz; Lorenzo Moja; Rachel Rosenthal; Shanil Ebrahim; Per O Vandvik; Bradley C Johnston; Martin A Walter; Bernard Burnand; Matthias Schwenkglenks; Lars G Hemkens; Heiner C Bucher; Gordon H Guyatt; Matthias Briel
Journal:  BMJ       Date:  2014-07-16
  10 in total
  4 in total

1.  Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

Authors:  Helena Earl; Louise Hiller; Anne-Laure Vallier; Shrushma Loi; Karen McAdam; Luke Hughes-Davies; Daniel Rea; Donna Howe; Kerry Raynes; Helen B Higgins; Maggie Wilcox; Chris Plummer; Betania Mahler-Araujo; Elena Provenzano; Anita Chhabra; Sophie Gasson; Claire Balmer; Jean E Abraham; Carlos Caldas; Peter Hall; Bethany Shinkins; Christopher McCabe; Claire Hulme; David Miles; Andrew M Wardley; David A Cameron; Janet A Dunn
Journal:  Health Technol Assess       Date:  2020-08       Impact factor: 4.014

2.  Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.

Authors:  Peter Lance; David S Alberts; Patricia A Thompson; Liane Fales; Fang Wang; Jerilyn San Jose; Elizabeth T Jacobs; Phyllis J Goodman; Amy K Darke; Monica Yee; Lori Minasian; Ian M Thompson; Denise J Roe
Journal:  Cancer Prev Res (Phila)       Date:  2016-10-24

Review 3.  Effect of Smoking on Treatment Efficacy and Toxicity in Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  Marie Bergman; Georgios Fountoukidis; Daniel Smith; Johan Ahlgren; Mats Lambe; Antonios Valachis
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

4.  Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error.

Authors:  James A Watson; Chris C Holmes
Journal:  Trials       Date:  2020-02-10       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.